Open AccessEfficacy and Safety of tDCS and tACS in Treatment of Major Depressive Disorder: A Randomized, Double-Blind, Factorial Placebo-Controlled Study Design
Author(s) -
Yuxin Huang,
Linjie Shen,
Jia Huang,
Xianrong Xu,
Yong Wang,
Hua Jin
Publication year - 2021
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s295945
Subject(s) - escitalopram , placebo , medicine , transcranial direct current stimulation , randomized controlled trial , adverse effect , transcranial alternating current stimulation , randomization , placebo controlled study , antidepressant , anesthesia , physical therapy , psychiatry , transcranial magnetic stimulation , stimulation , double blind , anxiety , pathology , alternative medicine
Transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS) are regarded as promising antidepressant treatments.